The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients
(Q44671845)
scientific article
scientific article
Language:
| (P31) |
(Q13442814)
|
||||||||||||||||||||||||
| (P304) |
1757-1763
|
||||||||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||||||||
| (P433) |
10
|
||||||||||||||||||||||||
| (P478) |
42
|
||||||||||||||||||||||||
| (P577) |
Saturday, November 1, 2003
|
||||||||||||||||||||||||
| (P921) |
(Q111140)
(Q424771)
(Q844935)
|
||||||||||||||||||||||||
| (P1433) |
(Q2984355)
|
||||||||||||||||||||||||
| (P1476) |
"The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients" (language: en)
|
||||||||||||||||||||||||
| (P2093) |
Jagdip S Sidhu
Dahlia Cowan
Juan-Carlos Kaski
|